These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 31259608

  • 1. Day of Ascent Dosing of Acetazolamide for Prevention of Acute Mountain Sickness.
    Lipman GS, Jurkiewicz C, Winstead-Derlega C, Navlyt A, Burns P, Walker A, Phillips C, Reilly A, Burnier A, Romero J, Warner K, Hackett P.
    High Alt Med Biol; 2019 Sep; 20(3):271-278. PubMed ID: 31259608
    [Abstract] [Full Text] [Related]

  • 2. A Randomized Controlled Trial of the Lowest Effective Dose of Acetazolamide for Acute Mountain Sickness Prevention.
    Lipman GS, Jurkiewicz C, Burnier A, Marvel J, Phillips C, Lowry C, Hawkins J, Navlyt A, Swenson ER.
    Am J Med; 2020 Dec; 133(12):e706-e715. PubMed ID: 32479750
    [Abstract] [Full Text] [Related]

  • 3. Prophylactic low-dose acetazolamide reduces the incidence and severity of acute mountain sickness.
    van Patot MC, Leadbetter G, Keyes LE, Maakestad KM, Olson S, Hackett PH.
    High Alt Med Biol; 2008 Dec; 9(4):289-93. PubMed ID: 19115912
    [Abstract] [Full Text] [Related]

  • 4. Altitude Sickness Prevention with Ibuprofen Relative to Acetazolamide.
    Burns P, Lipman GS, Warner K, Jurkiewicz C, Phillips C, Sanders L, Soto M, Hackett P.
    Am J Med; 2019 Feb; 132(2):247-251. PubMed ID: 30419226
    [Abstract] [Full Text] [Related]

  • 5. Budesonide Versus Acetazolamide for Prevention of Acute Mountain Sickness.
    Lipman GS, Pomeranz D, Burns P, Phillips C, Cheffers M, Evans K, Jurkiewicz C, Juul N, Hackett P.
    Am J Med; 2018 Feb; 131(2):200.e9-200.e16. PubMed ID: 28668540
    [Abstract] [Full Text] [Related]

  • 6. Low-dose acetylsalicylic acid analog and acetazolamide for prevention of acute mountain sickness.
    Kayser B, Hulsebosch R, Bosch F.
    High Alt Med Biol; 2008 Feb; 9(1):15-23. PubMed ID: 18331216
    [Abstract] [Full Text] [Related]

  • 7. Acetazolamide 125 mg BD is not significantly different from 375 mg BD in the prevention of acute mountain sickness: the prophylactic acetazolamide dosage comparison for efficacy (PACE) trial.
    Basnyat B, Gertsch JH, Holck PS, Johnson EW, Luks AM, Donham BP, Fleischman RJ, Gowder DW, Hawksworth JS, Jensen BT, Kleiman RJ, Loveridge AH, Lundeen EB, Newman SL, Noboa JA, Miegs DP, O'Beirne KA, Philpot KB, Schultz MN, Valente MC, Wiebers MR, Swenson ER.
    High Alt Med Biol; 2006 Feb; 7(1):17-27. PubMed ID: 16544963
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of low-dose acetazolamide (125 mg BID) for the prophylaxis of acute mountain sickness: a prospective, double-blind, randomized, placebo-controlled trial.
    Basnyat B, Gertsch JH, Johnson EW, Castro-Marin F, Inoue Y, Yeh C.
    High Alt Med Biol; 2003 Feb; 4(1):45-52. PubMed ID: 12713711
    [Abstract] [Full Text] [Related]

  • 9. Reduced Acetazolamide Dosing in Countering Altitude Illness: A Comparison of 62.5 vs 125 mg (the RADICAL Trial).
    McIntosh SE, Hemphill M, McDevitt MC, Gurung TY, Ghale M, Knott JR, Thapa GB, Basnyat B, Dow J, Weber DC, K Grissom C.
    Wilderness Environ Med; 2019 Mar; 30(1):12-21. PubMed ID: 30630671
    [Abstract] [Full Text] [Related]

  • 10. Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT).
    Gertsch JH, Basnyat B, Johnson EW, Onopa J, Holck PS.
    BMJ; 2004 Apr 03; 328(7443):797. PubMed ID: 15070635
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of acetazolamide on pulmonary artery pressure and prevention of high-altitude pulmonary edema after rapid active ascent to 4,559 m.
    Berger MM, Sareban M, Schiefer LM, Swenson KE, Treff F, Schäfer L, Schmidt P, Schimke MM, Paar M, Niebauer J, Cogo A, Kriemler S, Schwery S, Pickerodt PA, Mayer B, Bärtsch P, Swenson ER.
    J Appl Physiol (1985); 2022 Jun 01; 132(6):1361-1369. PubMed ID: 35511718
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prevention of acute mountain sickness by acetazolamide in Nepali porters: a double-blind controlled trial.
    Hillenbrand P, Pahari AK, Soon Y, Subedi D, Bajracharya R, Gurung P, Lal BK, Marahatta R, Pradhan S, Rai D, Sharma S, Birmingham Medical Research Expeditionary Society.
    Wilderness Environ Med; 2006 Jun 01; 17(2):87-93. PubMed ID: 16805144
    [Abstract] [Full Text] [Related]

  • 15. Reappraisal of acetazolamide for the prevention of acute mountain sickness: a systematic review and meta-analysis.
    Kayser B, Dumont L, Lysakowski C, Combescure C, Haller G, Tramèr MR.
    High Alt Med Biol; 2012 Jun 01; 13(2):82-92. PubMed ID: 22724610
    [Abstract] [Full Text] [Related]

  • 16. Ginkgo biloba does--and does not--prevent acute mountain sickness.
    Leadbetter G, Keyes LE, Maakestad KM, Olson S, Tissot van Patot MC, Hackett PH.
    Wilderness Environ Med; 2009 Jun 01; 20(1):66-71. PubMed ID: 19364166
    [Abstract] [Full Text] [Related]

  • 17. Identifying the lowest effective dose of acetazolamide for the prophylaxis of acute mountain sickness: systematic review and meta-analysis.
    Low EV, Avery AJ, Gupta V, Schedlbauer A, Grocott MP.
    BMJ; 2012 Oct 18; 345():e6779. PubMed ID: 23081689
    [Abstract] [Full Text] [Related]

  • 18. Ginkgo biloba and acetazolamide prophylaxis for acute mountain sickness: a randomized, placebo-controlled trial.
    Chow T, Browne V, Heileson HL, Wallace D, Anholm J, Green SM.
    Arch Intern Med; 2005 Feb 14; 165(3):296-301. PubMed ID: 15710792
    [Abstract] [Full Text] [Related]

  • 19. Altitude, Acute Mountain Sickness, and Acetazolamide: Recommendations for Rapid Ascent.
    Toussaint CM, Kenefick RW, Petrassi FA, Muza SR, Charkoudian N.
    High Alt Med Biol; 2021 Mar 14; 22(1):5-13. PubMed ID: 32975448
    [Abstract] [Full Text] [Related]

  • 20. Ginkgo biloba for the prevention of severe acute mountain sickness (AMS) starting one day before rapid ascent.
    Gertsch JH, Seto TB, Mor J, Onopa J.
    High Alt Med Biol; 2002 Mar 14; 3(1):29-37. PubMed ID: 12006162
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.